This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mor Research Applications Ltd.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Zoharia Evron: Innovator in Renin-Angiotensin System Treatment
Introduction
Zoharia Evron is a notable inventor based in Hod-Hasharon, Israel. He has made significant contributions to the field of medical treatment, particularly in the area of renal, vascular, and cartilage pathology. His innovative approach focuses on the inhibition of the renin-angiotensin system, which plays a crucial role in various diseases.
Latest Patents
Zoharia Evron holds 1 patent for his groundbreaking work titled "Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology." This patent discloses a method for treating diseases where up-regulating glycosaminoglycans (GAGs) is therapeutically beneficial, specifically targeting conditions such as osteoarthritis and skin diseases. The method involves the local administration of a therapeutically effective amount of an agent that can down-regulate the activity or expression of a component of the renin-angiotensin system.
Career Highlights
Zoharia Evron is associated with Mor Research Applications Ltd., where he continues to develop and refine his innovative medical treatments. His work has the potential to significantly impact the treatment of various conditions, improving the quality of life for many patients.
Collaborations
Zoharia collaborates with talented individuals in his field, including Talia Weinstein and Uzi Gafter. Their combined expertise enhances the research and development efforts at Mor Research Applications Ltd.
Conclusion
Zoharia Evron's contributions to medical innovation, particularly in the treatment of renal and vascular conditions, highlight his role as a significant inventor in the field. His patent reflects a promising approach to addressing complex health issues, showcasing the importance of innovation in medicine.